Research Areas

PHILADELPHIA—Bio-Rad Laboratories and Infometrix announced a new informatics application called AnalyzeIt MVP

BALTIMORE—Researchers at Johns Hopkins University (JHU), the University Würzburg, and the Institute of Bioinformatics (IOB)raised significant questions about current drug development assumptions

TEL AVIV, Israel—Compugen Ltd. announced it is leading a consortium to simulate the MAP-kinase pathway, a signaling pathway related to cancer

WEST LAFAYETTE, Ind.—BASi and the Indiana Centers for Applied Protein Sciences (INCAPS), have agreed to bring their respective contract research strengths together in a corporate alliance

BOSTON—PerkinElmer announced it acquired labeling technology from Agilix that uses isobaric mass tags for molecular quantification

TEL AVIV, Israel—The work with the SIMAP consortium and the mitogen-activated protein kinase pathway isn’t Compugen Ltd.’s only recent advance in the area of proteomics work.

VENLO, The Netherlands—Qiagenhas entered into a protein crystallography co-marketing agreement with ActiveSight

GENEVA—The Drugs for Neglected Diseases Initiative (DNDi) received a €9.5-million grant from the United Kingdom’s Department of International Development (DFID)for development of drugs for tropical diseases

MALVERN, Penn.—Novavax announced a collaborative agreement with the University of Pittsburgh School of Medicine to evaluate virus-like particle (VLP) influenza vaccines and the Novasome delivery adjuvant

LAVAL, Quebec—REPLICor and NIAID Rocky Mountain Laboratories collaborated on a therapeutic that may help fight prion disorders, including mad cow and Creutzfeld-Jakob disease